Royston, United Kingdom

John Gawain Elvin

USPTO Granted Patents = 8 

 


Average Co-Inventor Count = 11.9

ph-index = 3

Forward Citations = 418(Granted Patents)


Location History:

  • Meldreth, GB (2011)
  • Royston, GB (2014 - 2015)
  • Cambridge, GB (2005 - 2018)

Company Filing History:


Years Active: 2005-2018

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: John Gawain Elvin: A Visionary Inventor Shaping the Future

Introduction:

John Gawain Elvin is a remarkable inventor whose dedication to innovation is shaping a better future. Hailing from Royston, GB, he has made significant contributions to the field of healthcare through his visionary ideas and patented inventions.

Latest Patents:

With a total of 8 patents to his name, John Gawain Elvin's latest breakthrough includes the development of Anti-Siglec-15 antibodies and their uses in the treatment of leukaemia, particularly acute myeloid leukaemia. This innovative approach holds promise for improving the lives of patients battling this challenging disease.

Career Highlights:

Throughout his career, John Gawain Elvin has worked with reputable companies such as Abbott GmbH & Co. Kg and Medimmune Limited. His expertise and passion for innovation have been instrumental in driving groundbreaking research and development projects in the healthcare sector.

Collaborations:

Collaborating with esteemed colleagues like Jochen G Salfeld and Michael Roguska, John Gawain Elvin has consistently pushed the boundaries of invention and technology. Together, they have worked on cutting-edge projects that have the potential to revolutionize healthcare and make a lasting impact on society.

Conclusion:

John Gawain Elvin's pioneering spirit and commitment to creating positive change through innovation continue to inspire the next generation of inventors. His visionary ideas and patented inventions stand as a testament to his unwavering dedication to improving the world we live in.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…